Penault-Llorca, Frédérique
Kerr, Keith M.
Garrido, Pilar
Thunnissen, Erik
Dequeker, Elisabeth
Normanno, Nicola
Patton, Simon J.
Fairley, Jenni
Kapp, Joshua
de Ridder, Daniëlle
Ryška, Aleš
Moch, Holger http://orcid.org/0000-0002-7986-2839
Funding for this research was provided by:
Amgen (Europe) GmbH
University of Zurich
Article History
Received: 16 December 2021
Revised: 16 May 2022
Accepted: 18 May 2022
First Online: 20 July 2022
Declarations
:
: FP-L has provided consultancy for AbbVie, Amgen, AstraZeneca, Bayer, BMS, Clovis, Daiichi Sankyo, Diaceutics, Eli Lilly, Illumina, Invitae, MSD, Novartis, Pfizer, Roche, and Ventana, and has received research grants from AbbVie, AstraZeneca, Bayer, BMS, Illumina, MSD, and Roche. KMK has provided consultancy for AbbVie, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Diaceutics, Eli Lilly, Merck Serono, Merck Sharp & Dohme, Novartis, Pfizer, Roche, and Ventana. PG has provided consultancy for AbbVie, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche, and Takeda. She has been a speaker for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Merck Sharp & Dohme, Novartis, Pfizer, Roche, and Takeda. ET has received honoraria from Amgen, Bayer, BMS, MSD, Pfizer, Roche, and Takeda, and grants to VU Medical Center from AbbVie and Pfizer. ED has received grants from Amgen, AstraZeneca, and Pfizer. NN has received speaker’s fees from and/or participated in advisory boards for AstraZeneca, Bayer, Biocartis, BMS, Eli Lilly, Illumina, Incyte, Novartis, Merck, MSD, Qiagen, Roche, Sanofi, and Thermo Fisher; and financial support for research projects from AstraZeneca, Biocartis, Blueprint, Illumina, Merck, QIAGEN, Roche, and Thermo Fisher. SJP has received honoraria from AstraZeneca, and grants from Amgen, AstraZeneca, and Merck. JF has provided consultancy for Eli Lilly. JK is employed by Amgen and has stocks/shares in Amgen. DdR is employed by Amgen. AR has received honoraria from Amgen, AstraZeneca, BMS, Boehringer Ingelheim, MSD, Novartis, Pfizer, and Roche, and grants from AstraZeneca and Pfizer. HM has provided consultancy for AstraZeneca, Bayer, BMS, Diaceutics, and Roche, and has received research grants from Roche.